<DOC>
	<DOCNO>NCT02655731</DOCNO>
	<brief_summary>Aim present prospective , single-centre study determine outcome pure PVI use HeartLight™ 100 patient different extent LA-LVA . The latter assess electro-anatomical voltage map use commercial 3D map system ( CARTO , Biosense Webster ) .</brief_summary>
	<brief_title>HeartLight Guided - Pure Pulmonary Vein Isolation Regardless Concomitant Atrial Substrate</brief_title>
	<detailed_description>The ablation strategy patient atrial fibrillation ( AF ) concomitant atrial substrate ( e.g . low-voltage area ; LVA ) matter controversy . Results study investigate impact LVA may confound PV-to-left-atrial ( LA ) reconnection due non-durable ablation . Therefore , true contribution LA-LVA AF recurrences remain unknown . Meanwhile , new ablation technology HeartLight™ laser balloon ( LB ) ablation system provide near complete chronic PVI rate develop . Aim present prospective , single-centre study determine outcome pure PVI use HeartLight™ 100 patient different extent LA-LVA . The latter assess electro-anatomical voltage map use commercial 3D map system ( CARTO , Biosense Webster ) .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic atrial fibrillation Left atrial size &lt; 50mm Left ventricular ejection fraction &lt; 45 % Patient able provide inform consent Contraindications PVI Previous PVI attempt Inability treat oral anticoagulation Presence intracardiac thrombus Pregnancy Participation clinical study Unwilling follow study protocol attend followup visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>